Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mastec (MTZ) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Mastec (MTZ) over the last 17 years, with Q3 2025 value amounting to $231.4 million.

  • Mastec's Cash & Equivalents rose 2769.65% to $231.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.4 million, marking a year-over-year increase of 2769.65%. This contributed to the annual value of $399.9 million for FY2024, which is 2448.41% down from last year.
  • As of Q3 2025, Mastec's Cash & Equivalents stood at $231.4 million, which was up 2769.65% from $191.1 million recorded in Q2 2025.
  • In the past 5 years, Mastec's Cash & Equivalents registered a high of $529.6 million during Q4 2023, and its lowest value of $95.7 million during Q3 2022.
  • Moreover, its 5-year median value for Cash & Equivalents was $237.3 million (2021), whereas its average is $267.9 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 61502.31% in 2021, then plummeted by 6012.24% in 2022.
  • Mastec's Cash & Equivalents (Quarter) stood at $360.7 million in 2021, then increased by 2.73% to $370.6 million in 2022, then soared by 42.9% to $529.6 million in 2023, then decreased by 24.48% to $399.9 million in 2024, then tumbled by 42.13% to $231.4 million in 2025.
  • Its Cash & Equivalents stands at $231.4 million for Q3 2025, versus $191.1 million for Q2 2025 and $345.7 million for Q1 2025.